mjc159/others: First and foremost: SORRY for mistyping in my previous post as the correct spelling of course is ACADIA !
mjc159: Thanks for your reply. Yes, indeed, ACADIA just might like Switzerland as a location - even though it is a very high-priced country within Europe and with a very small domestic market... I was just trying to think a bit "outside the box" - but perhaps wrongly, naturally! However, I believe that NOVARTIS (more than enough cashed-up and with some interests in 'rare diseases') could be a company that could take-over both ACADIA as well as NEU - IF they would really be interested.... I am most curious to see where the ROW will go. And when. Moreover, I would NOT like to see ACADIA getting those. But this is just me, perhaps?
wasa
NEU Price at posting:
$7.13 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)